314 related articles for article (PubMed ID: 36284987)
1. Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation.
Bao W; Sun H; Wu X; Xu J; Zhang H; Cao L; Fan Y
Dis Markers; 2022; 2022():1927688. PubMed ID: 36284987
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
Wei S; Li J; Han DW; Fu Q; Hao F
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
[TBL] [Abstract][Full Text] [Related]
4. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of the effect of Gegen Qinlian decoction on COVID-19 comorbid with diabetes mellitus based on network pharmacology and molecular docking: A review.
Li LZ; Zhou C; Wang P; Ke QH; Zhang J; Lei SS; Li ZQ
Medicine (Baltimore); 2023 Nov; 102(44):e34683. PubMed ID: 37933071
[TBL] [Abstract][Full Text] [Related]
6. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
[TBL] [Abstract][Full Text] [Related]
8. Integrated serum pharmacochemistry and network pharmacology analyses reveal the bioactive metabolites and potential functional mechanism of ground cherry (Physalis pruinosa L.) in treatment of type 2 diabetes mellitus in rats.
Mahana A; Hammoda HM; Khalifa AA; Elblehi SS; Harraz FM; Shawky E
J Ethnopharmacol; 2023 Jan; 300():115750. PubMed ID: 36162547
[TBL] [Abstract][Full Text] [Related]
9. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
10. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Si-Wu Decoction in the treatment of ulcerative colitis revealed by network pharmacology and experimental verification.
Wang L; Liu Y; Shen G; He G; Qiu S; Li B
J Ethnopharmacol; 2023 Dec; 317():116847. PubMed ID: 37356743
[TBL] [Abstract][Full Text] [Related]
12. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.
Pan L; Li Z; Wang Y; Zhang B; Liu G; Liu J
J Ethnopharmacol; 2020 Aug; 258():112842. PubMed ID: 32333952
[TBL] [Abstract][Full Text] [Related]
14. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
15. Huayuwendan decoction ameliorates inflammation via IL-17/NF-κB signaling pathway in diabetic rats.
Wang H; Pan F; Liu J; Zhang J; Fuli Zhang ; Wang Y
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117328. PubMed ID: 37865275
[TBL] [Abstract][Full Text] [Related]
16. Qinlian hongqu decoction ameliorates hyperlipidemia via the IRE1-α/IKKB-β/NF-κb signaling pathway: Network pharmacology and experimental validation.
Zhang Y; Guo Z; Wang J; Yue Y; Yang Y; Wen Y; Luo Y; Zhang X
J Ethnopharmacol; 2024 Jan; 318(Pt A):116856. PubMed ID: 37406747
[TBL] [Abstract][Full Text] [Related]
17. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
18. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
19. [Anti-inflammatory mechanism of active ingredients in Jingfang Mixture based on network pharmacology and experimental verification].
Feng Q; Sun CH; Li SR; Li XZ; Xiao M; Zhao T; Zhang GM
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5481-5487. PubMed ID: 36471963
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of Huangbaichen Sanwei formulation in treating T2DM based on network pharmacology and molecular docking.
Li C; Shen J; Jing X; Zhang K; Liu L; Wang Y; Zhang H; Sun J
Medicine (Baltimore); 2023 Nov; 102(46):e36146. PubMed ID: 37986298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
